Titre:pharmaceutical manufacturers unither: bfs, effervescent tablet, powder and liqui
La description :unither pharmaceuticals, a world-leading pharmaceutical contract development manufacturing organization (cdmo) in affordable, innovative and convenient single unit dosage forms that simplify the lives...
Classement Alexa Global: # 1,808,976
Server:Apache...
L'adresse IP principale: 217.117.146.60,Votre serveur France,Isle ISP:Telecitygroup International Limited TLD:com Code postal:fr
Ce rapport est mis à jour en 08-Nov-2018
Created Date: | 2002-05-21 |
Changed Date: | 2015-04-16 |
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte unither-pharma.com.Actuellement, hébergé dans France et son fournisseur de services est Telecitygroup International Limited .
Latitude: | 45.802719116211 |
Longitude: | 1.2121299505234 |
Pays: | France (fr) |
Ville: | Isle |
Région: | Limousin |
ISP: | Telecitygroup International Limited |
domaine | Titre |
---|---|
unither-pharma.com | pharmaceutical manufacturers unither: bfs, effervescent tablet, powder and liqui |
symonbali.com | balinese teak furniture manufacturers | indonesian teak furniture manufacturers |
rubber-wristbands.com | silicone wristband manufacturers|silicone bracelets manufacturers - silicone wri |
lca-pharma.com | lca pharmaceutical |
pharmaceutical-technology.com | pharmaceutical technology |
pps.com.pl | polish pharmaceutical services |
pjpr.net | pakistan journal of pharmaceutical research |
pcne.org | pharmaceutical care network europe |
cmimedia.com | a pharmaceutical marketing agency – cmi media, llc |
seavision.it | sea vision - pharmaceutical inspection and serialization systems |
biogaran.com | biogaran – a pharmaceutical laboratory – generic medicines |
europa-trial.org | servier - an international and independant pharmaceutical group |
ethypharm.fr | ethypharm develops value adding pharmaceutical products |
ipharmaconference.com | 3rd global pharma conference | pharmaceutical congress uk |
ethypharm.com | ethypharm develops value adding pharmaceutical products |
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
Content-Encoding: | gzip |
Transfer-Encoding: | chunked |
Set-Cookie: | 40b0a3c15f3c83497a798a76013b0fa4=djp3na9n7jcbm16m9vmkh64o80; path=/; HttpOnly, nrid=48cb330842c312b3; expires=Wed, 15-Sep-2021 06:29:06 GMT; Max-Age=90000000; path=/ |
Expires: | Wed, 17 Aug 2005 00:00:00 GMT |
Keep-Alive: | timeout=5, max=100 |
Server: | Apache |
Last-Modified: | Thu, 08 Nov 2018 14:29:07 GMT |
Connection: | Keep-Alive |
Pragma: | no-cache |
Cache-Control: | no-store, no-cache, must-revalidate, post-check=0, pre-check=0 |
Date: | Thu, 08 Nov 2018 14:29:06 GMT |
Content-Type: | text/html; charset=utf-8 |
soa: | a.dns.gandi.net. hostmaster.gandi.net. 1539937894 10800 3600 604800 10800 |
txt: | "ppkey-df792bf66265918de88a429e7141c41d" "v=spf1 mx a ip4:217.117.146.32/27 ip4:84.14.49.24/29 include:outlook.com include:pepipost.net ~all" |
ns: | b.dns.gandi.net. a.dns.gandi.net. c.dns.gandi.net. |
ipv4: | IP:217.117.146.60 ASN:15830 OWNER:TELECITY-LON, GB Country:FR |
mx: | MX preference = 0, mail exchanger = unitherpharma-com01i.mail.protection.outlook.com. MX preference = 200, mail exchanger = mr.unither-pharma.com. MX preference = 100, mail exchanger = ms67103014.msv1.invalid.outlook.com. |
events global global europe north america south america 简体中文(中国) about us back our vision, mission, and values our history our locations back europe north america south america technologies back blow fill seal (bfs) liquid stick packs powder stick-packs tablets pharmaceuticals bottles suppositories and pessaries r&d and innovation back pharmaceutical r&d back pharmaceutical drug development medical devices analytical services clinical batches i-ii clinical batches ii-iii primary packaging ich stability r&d at manufacturing sites back amiens, coutances, france colomiers, france gannat, france rochester : pharmaceutical company in usa innovation back uniflash® odtech orphan drugs regulatory expertise medical doctors licensing & partnering back 3 types of collaboration partner with unither product portfolio product development inquiry careers back why unither values in action working at unither join us contact us unither pharmaceuticals single best way to deliver unither pharmaceuticals, a world-leading pharmaceutical contract development manufacturing organization (cdmo) in affordable, innovative and convenient single unit dosage forms that simplify the lives of patients. read more innovation "bb dose" in collaboration with biolane the "bb dose" guarantees a greater safety of the gesture with the infant thanks to the development of a sterile unit-dose with a more rounded tip that fits perfectly with baby's nostrils. read more sterile dosage forms blow-fill-seal (bfs) we are the world’s number one producer of bfs products, and we have been making these products since 1993. they allow preservative-free formulations, are convenient, portable, and cost-effective. read more liquid dosage forms unistick ® liquid stick-pack an alternative to the sterile unit dose, the unistick® contains a premeasured dose of liquid, and is robust, easy-to-open and portable. an excellent choice for oral and topical delivery. read more expertise & innovation drug development services 25 years of experience in taking pharmaceutical development projects from very early stages to commercial scale-up. read more solid dosage forms unistick ® powder stick-pack portable and convenient for modern on-the-go lifestyles, unistick ® makes medications easier to take. powder can be dissolved into a liquid, or taken directly into the mouth. read more 1 2 3 4 5 6 all article corporate events press releases default title date random new: specialized transmucosal paracetamol solutions new technology acquisition provides unither pharmaceuticals with specialized transmucosal paracetamol solutions preliminary clinical trials have shown that this technology would … read more adpvk humanitarian association & unither partnership since 2017 unither pharmaceuticals contributes to adpvk (development association of the kou valley fisherman camp) that was founded by emanuel sanou kou, a valley fisherman … read more single best way to deliver single best way to deliver with more than 25 years of experience in drug products and medical devices development for … read more adpvk & unither pharmaceuticals unither pharmaceuticals decided to contribute to adpvk (development association of the kou valley fisherman camp) that was founded by emanuel … read more article press releases healthcare packaging magazine unither pharmaceuticals shares serialization experiences by jim chrzan, publisher regardless of eu requirements, aggregation could be the most accurate way to succeed with a serialization … read more article corporate unither pharmaceuticals: a patient-centric drug developer and manufacturer achieving success with a new drug therapy is increasingly dependent on dose form and delivery systems that support therapeutic compliance … read more article corporate load more hold shift key to load all load all © 2018 unither home news events contact ⬆
https://www.unither-pharma.com/phamaceutical-rd/ich-stability
https://www.unither-pharma.com/rd-and-innovation/experience-and-capabilities
https://www.unither-pharma.com/technologies/odx
https://www.unither-pharma.com/about-us/timeline
https://www.unither-pharma.com/innovation/an-injection-without-the-needle
https://www.unither-pharma.com/phamaceutical-rd/analytical-services
https://www.unither-pharma.com/fr/
https://www.unither-pharma.com/events
https://www.unither-pharma.com/licensing-partnering/single-best-way-to-deliver
https://www.unither-pharma.com/licensing-partnering/true-collaboration
https://www.unither-pharma.com/news/new-specialized-transmucosal-paracetamol-solutions
https://www.unither-pharma.com/rd-at-manufacturing-sites/liquids-manufacturing-for-clinical-trials
https://www.unither-pharma.com/contact-us
https://www.unither-pharma.com/rd-and-innovation/new-challenges-new-solutions
https://www.unither-pharma.com/press-releases/adpvk-humanitarian-association-unither-partnership
biolane.fr
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: UNITHER-PHARMA.COM
Registry Domain ID: 86793137_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.gandi.net
Registrar URL: http://www.gandi.net
Updated Date: 2015-04-16T11:47:47Z
Creation Date: 2002-05-21T14:02:30Z
Registry Expiry Date: 2020-05-21T14:02:30Z
Registrar: Gandi SAS
Registrar IANA ID: 81
Registrar Abuse Contact Email: abuse@support.gandi.net
Registrar Abuse Contact Phone: +33.170377661
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: A.DNS.GANDI.NET
Name Server: B.DNS.GANDI.NET
Name Server: C.DNS.GANDI.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-09-17T07:34:31Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Gandi SAS
SERVERS
SERVER com.whois-servers.net
ARGS domain =unither-pharma.com
PORT 43
TYPE domain
RegrInfo
DOMAIN
NAME unither-pharma.com
CHANGED 2015-04-16
CREATED 2002-05-21
STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
A.DNS.GANDI.NET 173.246.98.1
B.DNS.GANDI.NET 213.167.229.1
C.DNS.GANDI.NET 217.70.179.1
REGISTERED yes
La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.